ArticleBMC pediatrics2026
Effect of blue LED phototherapy on oxidative stress and DNA damage in term and preterm infants with hyperbilirubinemia.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePhototherapy is the first-line treatment for neonatal hyperbilirubinemia. Despite its widespread use, concerns persist regarding the potential biological effects of phototherapy beyond bilirubin reduction, particularly in vulnerable populations such as preterm infants. Comparative data evaluating oxidative stress and DNA damage (8-OHdG) in response to phototherapy in term versus preterm neonates are limited. This study evaluated the association between blue LED phototherapy and oxidative stress and 8-OHdG in both term and preterm newborns.
methodsThis study was a prospective exploratory cohort study with repeated measurements of oxidative stress markers before and after phototherapy. We included 20 term and 20 preterm infants receiving phototherapy as study group and 17 term and 19 preterm as reference group without phototherapy. Blood samples were collected before (pre) and 24 h after (post) phototherapy to assess total antioxidant capacity (TAC), total oxidative status (TOS), and 8-OHdG in the study group while the reference group had single initial measurements. Multivariable adjustment for baseline differences (gestational age and baseline total bilirubin) and an adjusted repeated-measures analysis were performed.
resultsBefore phototherapy, there was no significant difference in TAC, TOS, or 8-OHdG between the term study and reference groups or between the preterm study and reference groups after adjustment for gestational age and baseline total bilirubin. Similar to the univariate analysis, in term study group there was no significant difference in pre and post TAC, TOS, and 8-OHdG, while in preterm study group, pre and post TAC, TOS, 8-OHdG levels were significantly decreased after adjustment analysis for gestational age and baseline total bilirubin. Preterm study group had lower pre and post TOS and 8-OHdG and post TAC than term study group, whereas pre TAC was similar.
conclusionBlue LED phototherapy was associated with lower oxidative stress and DNA damage markers in preterm newborns but not in term newborns. These findings suggest a gestational age–dependent biochemical response to phototherapy, potentially mediated by bilirubin-related redox balance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.